Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma-Reference-Cited by-同舟云学术

Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma

Published:2008-12-01 Issue:11 Volume:113 Page:3169-3180
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

dos Reis Patricia Pintor,Bharadwaj Rikki R.,Machado Jerry,MacMillan Christina,Pintilie Melania,Sukhai Mahadeo A.,Perez-Ordonez Bayardo,Gullane Patrick,Irish Jonathan,Kamel-Reid Suzanne

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. A comprehensive review of oral cancer;Casiglia;Gen Dent,2001

2. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database;Carvalho;Int J Cancer,2005

3. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis;Warner;Int J Cancer,2004

4. Claudins at the gate: determinants of renal epithelial tight junction paracellular permeability;Balkovetz;Am J Physiol Renal Physiol,2006

5. The roles of claudin superfamily proteins in paracellular transport;Heiskala;Traffic,2001

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients;Discover Oncology;2024-08-29

2. Claudin-1 in Head and Neck Squamous Cell Carcinoma;Oncology;2024-08-14

3. Claudin-12: guardian of the tissue barrier or friend of tumor cells;Tissue Barriers;2024-08

4. The activation of adenosine monophosphate–activated protein kinase inhibits the migration of tongue squamous cell carcinoma cells by targeting Claudin‐1 via epithelial–mesenchymal transition;Animal Models and Experimental Medicine;2024-07-17

5. Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer;Oncogene;2024-06-28